Merck & Co., Inc. (BIT:1MRKX)

Italy flag Italy · Delayed Price · Currency is EUR
67.90
-0.80 (-1.16%)
Last updated: Apr 17, 2025
-42.75%
Market Cap 172.61B
Revenue (ttm) 61.98B
Net Income (ttm) 16.53B
Shares Out n/a
EPS (ttm) 6.51
PE Ratio 10.44
Forward PE n/a
Dividend 2.93 (4.32%)
Ex-Dividend Date Mar 14, 2025
Volume 27
Average Volume 256
Open 68.00
Previous Close 68.70
Day's Range 67.90 - 68.00
52-Week Range 67.10 - 126.40
Beta n/a
RSI 24.69
Earnings Date Apr 24, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Industry Pharmaceutical Preparations
Founded 1891
Employees 75,000
Stock Exchange Borsa Italiana
Ticker Symbol 1MRKX
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.